Description

Cabozantinib Impurity 5 is a designated impurity reference standard used in the analytical profiling and quality control of the active pharmaceutical ingredient (API) Cabozantinib. This compound is critical for ensuring the purity, safety, and efficacy of the final drug product by serving as a benchmark in chromatographic analysis. It is primarily required by pharmaceutical manufacturers, analytical laboratories, and regulatory bodies involved in the development and quality assurance of Cabozantinib-based therapies.

Application

• Pharmaceutical Reference Standard: Used as a certified impurity standard for the identification and quantification of Cabozantinib Impurity 5 in Cabozantinib API and finished dosage forms.
• Method Development and Validation: Essential for developing, optimizing, and validating analytical methods, particularly High-Performance Liquid Chromatography (HPLC) and related techniques.
• Quality Control (QC) Testing: Employed in routine QC testing of Cabozantinib batches to monitor impurity levels and ensure compliance with International Council for Harmonisation (ICH) guidelines.
• Stability Studies: Used to track the formation of this specific impurity during forced degradation and long-term stability studies of the drug substance and product.
• Regulatory Submissions: Provides necessary data for regulatory filings (e.g., with the FDA, EMA) to establish impurity profiles and specifications.
• Research and Development: Supports impurity characterization, synthesis pathway optimization, and process-related impurity studies during API development.

Basic Information

Product Name	Cabozantinib Impurity 5
CAS No.	104330-60-1
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	Cabozantinib Related Compound 5; Cabozantinib Impurity; Cabozantinib Process Impurity; Cabozantinib Degradant; 1-N-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide Impurity; Cabozantinib Analog; Cabozantinib Specified Impurity
EINECS	Contact for details

Quality Control

Our Cabozantinib Impurity 5 is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing to ensure identity, purity, and consistency, meeting the high standards required for pharmaceutical reference materials. A comprehensive Certificate of Analysis (COA) is provided with each shipment, detailing results from tests such as HPLC purity, identity confirmation (e.g., by IR or MS), and residual solvent analysis.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature, typically between 15-25°C, in a dry environment. For long-term stability, storage under inert atmosphere may be recommended.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to reference spectrum
Purity (HPLC)	≥ 95.0%
Related Substances (HPLC)	Single impurity ≤ 1.0%; Total impurities ≤ 5.0%
Water Content (KF)	≤ 1.0%
Residual Solvents (GC)	Complies with ICH Q3C guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.